Regulation of interleukin-1 in acute brain injury

Trends in Pharmacological Sciences

Volumn 32, Issue 10, 2011, Pages 617-622

  Brough, David ^a   Tyrrell, Pippa J ^a   Allan, Stuart M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2 AMINOETHYLAMINO) 1,8 DIMETHYLIMIDAZO[1,2 A]QUINOXALINE; 4 [4 (4 FLUOROPHENYL) 5 (2 METHOXY 4 PYRIMIDINYL) 1 IMIDAZOLYL]CYCLOHEXANOL; B 27 HYD; CANAKINUMAB; CRYOPYRIN; GLIBENCLAMIDE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA ANTIBODY; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; N (3 PROPYLCARBAMOYLOXIRANE 2 CARBONYL)ISOLEUCYLPROLINE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; BRAIN INJURY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG TARGETING; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; RISK REDUCTION; SIGNAL TRANSDUCTION; STROKE;

ANIMALS; BRAIN INJURIES; HUMANS; INFLAMMATION; INTERLEUKIN-1;

EID: 80053360038     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2011.06.002     Document Type: Review

References (69)

1. M. Schwartz, and R. Shechter Systemic inflammatory cells fight off neurodegenerative disease Nat. Rev. Neurol. 6 2010 405 410
2. R. Shechter Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice PLoS Med. 6 2009 e1000113
3. J. Savill A blast from the past: clearance of apoptotic cells regulates immune responses Nat. Rev. Immunol. 2 2002 965 975 (Pubitemid 37323217)
4. J.M. Hallett Novel pharmacological strategies for driving inflammatory cell apoptosis and enhancing the resolution of inflammation Trends Pharmacol. Sci. 29 2008 250 257
5. J. Zhang A role for potassium permeability in the recognition, clearance, and anti-inflammatory effects of apoptotic cells Mol. Neurobiol. 42 2010 17 24
6. G.Y. Chen, and G. Nunez Sterile inflammation: sensing and reacting to damage Nat. Rev. Immunol. 10 2010 826 837
7. S.M. Allan Interleukin-1 and neuronal injury Nat. Rev. Immunol. 5 2005 629 640 (Pubitemid 41113194)
8. J. Mackay, and G. Mensah Atlas of heart disease and stroke 2004 World Health Organisation
9. H. Suzuki Caspase-1 inhibitor prevents neurogenic pulmonary edema after subarachnoid hemorrhage in mice Stroke 40 2009 3872 3875
10. B. Wu Ac-YVAD-CMK decreases blood-brain barrier degradation by inhibiting caspase-1 activation of interleukin-1beta in intracerebral hemorrhage mouse model Transl. Stroke Res. 1 2010 57 64
11. S.R. Clark Interleukin-1 receptor antagonist penetrates human brain at experimentally therapeutic concentrations J. Cereb. Blood Flow Metab. 28 2008 387 394 (Pubitemid 351161294)
12. J. Galea Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study J. Cereb. Blood Flow Metab. 31 2011 439 447
13. H.C. Emsley A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients J. Neurol. Neurosurg. Psychiatry 76 2005 1366 1372 (Pubitemid 41360973)
14. N.M. Luheshi Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy Br. J. Pharmacol. 157 2009 1318 1329
15. H. Kono Identification of the cellular sensor that stimulates the inflammatory response to sterile cell death J. Immunol. 184 2010 4470 4478
16. P. Thornton Platelet interleukin-1{alpha} drives cerebrovascular inflammation Blood 115 2010 3632 3639
17. K.L. Rock The sterile inflammatory response Ann. Rev. Immunol. 28 2010 321 342
18. O. Takeuchi, and S. Akira Pattern recognition receptors and inflammation Cell 140 2010 805 820
19. N.M. Luheshi The dynamics and mechanisms of interleukin-1alpha and beta nuclear import Traffic 10 2009 16 25
20. N.M. Luheshi Nuclear retention of IL-1 alpha by necrotic cells: a mechanism to dampen sterile inflammation Eur. J. Immunol. 39 2009 2973 2980
21. I. Cohen Differential release of chromatin-bound IL-1alpha discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation Proc. Natl. Acad. Sci. U.S.A. 107 2010 2574 2579
22. A. Mandinova S100A13 mediates the copper-dependent stress-induced release of IL-1alpha from both human U937 and murine NIH 3T3 cells J. Cell Sci. 116 2003 2687 2696 (Pubitemid 36857222)
23. C. Eder Mechanisms of interleukin-1beta release Immunobiology 214 2009 543 553
24. K. Schroder, and J. Tschopp The inflammasomes Cell 140 2010 821 832
25. H. Poeck Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production Nat. Immunol. 11 2010 63 69
26. S.L. Cassel, and F.S. Sutterwala Sterile inflammatory responses mediated by the NLRP3 inflammasome Eur. J. Immunol. 40 2010 607 611
27. D. Brough, and N.J. Rothwell Caspase-1-dependent processing of pro-interleukin-1 beta is cytosolic and precedes cell death J. Cell Sci. 120 2007 772 781 (Pubitemid 46523479)
28. W. Nickel, and C. Rabouille Mechanisms of regulated unconventional protein secretion Nat. Rev. Mol. Cell Biol. 10 2009 148 155
29. M. Lamkanfi Emerging inflammasome effector mechanisms Nat. Rev. Immunol. 11 2011 213 220
30. Y. Yin Inflammasomes are differentially expressed in cardiovascular and other tissues Int. J. Immunopathol. Pharmacol. 22 2009 311 322
31. J.A. Kummer Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response J. Histochem. Cytochem. 55 2007 443 452 (Pubitemid 46668626)
32. A. Halle The NALP3 inflammasome is involved in the innate immune response to amyloid-beta Nat. Immunol. 9 2008 857 865
33. V. Hornung, and E. Latz Critical functions of priming and lysosomal damage for NLRP3 activation Eur. J. Immunol. 40 2010 620 623
34. F. Martinon Signaling by ROS drives inflammasome activation Eur. J. Immunol. 40 2010 616 619
35. J.P. de Rivero Vaccari A molecular platform in neurons regulates inflammation after spinal cord injury J. Neurosci. 28 2008 3404 3414
36. J.P. de Rivero Vaccari Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury J. Cereb. Blood Flow Metab. 29 2009 1251 1261
37. D.P. Abulafia Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice J. Cereb. Blood Flow Metab. 29 2009 534 544
38. S.S. Iyer Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome Proc. Natl. Acad. Sci. U.S.A. 106 2009 20388 20393
39. H. Li Cutting edge: Necrosis activates the NLRP3 inflammasome J. Immunol. 183 2009 1528 1532
40. A.B. Imaeda Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome J. Clin. Invest. 119 2009 305 314
41. A. Benchoua Activation of proinflammatory caspases by cathepsin B in focal cerebral ischemia J. Cereb. Blood Flow Metab. 24 2004 1272 1279 (Pubitemid 39482490)
42. S. Jha The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18 J. Neurosci. 30 2010 15811 15820
43. G.J. Hankey Potential new risk factors for ischemic stroke: what is their potential? Stroke 37 2006 2181 2188 (Pubitemid 44309926)
44. H.C. Emsley, and S.J. Hopkins Acute ischaemic stroke and infection: recent and emerging concepts Lancet Neurol. 7 2008 341 353 (Pubitemid 351380535)
45. C. Drake Brain inflammation is induced by co-morbidities and risk factors for stroke Brain Behav. Immun. 2011 10.1016/j.bbi.2011.02.008
46. B. Vandanmagsar The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance Nat. Med. 17 2011 179 188
47. P. Duewell NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals Nature 464 2010 1357 1361
48. B. Schoch Analysis of intrathecal interleukin-6 as a potential predictive factor for vasospasm in subarachnoid hemorrhage Neurosurgery 60 2007 828 836
49. Clinical Effectiveness and Evaluation Unit (2008) Sentinel Audit Report on Stroke. Royal College of Physicians, London
50. D.J. Nieuwkamp Excess mortality and cardiovascular events in patients surviving subarachnoid hemorrhage: a nationwide study in sweden Stroke 42 2011 902 907
51. C.A. Dinarello Anti-inflammatory agents: present and future Cell 140 2010 935 950
52. Y. Yamasaki Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats Stroke 26 1995 676 680
53. J. Ross A selective, non-peptide caspase-1 inhibitor, VRT-018858, markedly reduces brain damage induced by transient ischemia in the rat Neuropharmacology 53 2007 638 642 (Pubitemid 47513170)
54. M. Lamkanfi Glyburide inhibits the cryopyrin/Nalp3 inflammasome J. Cell Biol. 187 2009 61 70
55. J.M. Simard Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke Stroke 40 2009 604 609
56. V. Hornung Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization Nat. Immunol. 9 2008 847 856
57. J. Anagli A novel calpastatin-based inhibitor improves postischemic neurological recovery Biochem. Biophys. Res. Commun. 385 2009 94 99
58. D.E. Goll The calpain system Physiol. Rev. 83 2003 731 801 (Pubitemid 36828925)
59. F.C. Barone Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia Med. Res. Rev. 21 2001 129 145 (Pubitemid 32185244)
60. O. Herrmann IKK mediates ischemia-induced neuronal death Nat. Med. 11 2005 1322 1329 (Pubitemid 41752913)
61. A.L. Hopkins Network pharmacology: the next paradigm in drug discovery Nat. Chem. Biol. 4 2008 682 690
62. J. Lehar Synergistic drug combinations tend to improve therapeutically relevant selectivity Nat. Biotechnol. 27 2009 659 666
63. P. Pelegrin, and A. Surprenant Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates EMBO J. 28 2009 2114 2127
64. G. Lopez-Castejon Novel macrophage polarization model: from gene expression to identification of new anti-inflammatory molecules Cell Mol. Life Sci. 2010 10.1007/s00018-010-0609-y
65. G. Bannenberg, and C.N. Serhan Specialized pro-resolving lipid mediators in the inflammatory response: an update Biochim. Biophys. Acta 1801 2010 1260 1273
66. H. Hasturk Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo J. Immunol. 179 2007 7021 7029
67. Y. Jin Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators Invest. Ophthalmol. Vis. Sci. 50 2009 4743 4752
68. V.E. O'Collins 1,026 experimental treatments in acute stroke Ann. Neurol. 59 2006 467 477 (Pubitemid 43358067)
69. M. Fisher Update of the stroke therapy academic industry roundtable preclinical recommendations Stroke 40 2009 2244 2250